Fundamentals of HIV Medicine 2019

Cover
W. David Hardy
Oxford University Press, 2019 - 584 Seiten
The essential work in HIV for providers and pharmacists -- updated with everything they need to know in 2019!

Assembled by the leading educational organization in HIV medicine, AAHIVM's Fundamentals of HIV Medicine 2019 is an end-to-end clinical resource for the treatment of individuals with HIV/AIDS. It offers state-of-the-art practical advice for physicians, pharmacists, nurse practitioners, and other professionals working in the care of HIV patients.

Along with updates to the classic domains of HIV medicine, this new edition features expanded coverage of emerging topics, including: behavioral and therapeutic interventions to HIV prevention; updates on the pursuit of a cure; new DHHS and IAS guidelines and their clinical implications; and the myriad issues around aging with HIV.

Embodying the American Academy of HIV Medicine's commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2019 is must-have for health professionals across HIV care, treatment, and prevention.

 

Inhalt

1 Epidemiology and the Spread of HIV
1
2 The Origin Evolution and Epidemiologyof HIV 1 and HIV 2
15
3 Mechanisms of HIV Transmission
21
4 HIV Transmission Prevention
25
5 Immunology
49
6 HIV Cure Strategies
59
7 HIV Testing and Counseling
67
8 Laboratory Testing Strategies Detectionand Diagnosis
73
28 Antiretroviral Therapy for Children and Newborns
287
29 Immunosuppressants and Antiretroviral Therapyin HIV Positive Transplant Patients
297
30 Understanding and Managing Antineoplastic andAntiretroviral Therapy
301
31 Substance Abuse in HIV Populations
309
32 Understanding the Use of Antiretrovirals in theAging Patient
317
33 Opportunistic Infections
323
34 Malignant Diseases in HIV
337
35 Dermatologic Complications
379

9 The Medical History and Physical Examination ofthe Patient with HIV
83
10 Initial Laboratory Evaluation and Risk Stratificationof the Patient with HIV
87
11 Recognition of Acute and Advanced HIV Infection
91
12 Health Maintenance
97
13 Issues in Specific Patient Populations
115
14 Complementary and AlternativeMedicine Integrative Medicine Approaches
157
15 HIV Care Coordination
175
16 The Pharmacists Role in Caring forHIV Positive Individuals
183
17 The Role of the Physician Assistant and the NursePractitioner in Caring for Persons Living with HIV
189
18 Hospice and Palliative Care in AdvancedHIV Disease
199
19 HIV Virology
205
20 Principles of Applied Clinical Pharmacokineticsand Pharmacodynamics in Antiretroviral Therapy
219
21 Classes of Antiretrovirals
225
Whatto Start With
239
23 HIV 1 Resistance to Antiretroviral Drugs
245
24 Managing the Patient with Multidrug Resistant HIV
257
25 Future Antiretrovirals Immune Based Strategiesand Therapeutic Vaccines
261
26 Solid Organ Transplantation in Persons Livingwith HIV
275
27 Antiretroviral Therapy in Pregnant Women
281
36 Endocrine and Metabolic Disorders
391
RespiratoryComplications
399
38 Psychiatric Illness and Treatment inHIV Populations
403
39 Neurological Effects of HIV Infection
413
40 HIV and Hepatitis Coinfection
433
41 Ocular Complications
447
42 Cardiovascular Disease
453
43 Renal Complications
469
44 Body Composition Changes Frailty andMusculoskeletal Complications of HIV
481
45 Sexually Transmitted Diseases
487
46 HIV and Bone Health
493
47 HIV Associated Lipodystrophy and Lipoatrophy
505
48 Immune Reconstitution InflammatorySyndrome IRIS
513
49 US Healthcare Systems HIV Programs andCoverage Policy Issues
519
50 Legal Issues
525
51 Research Design and Analysis
541
52 Ethical Conduct of Clinical Trials InstitutionalReview Boards Informed Consent and FinancialConflicts of Interest
545
Index
549
Urheberrecht

Andere Ausgaben - Alle anzeigen

Häufige Begriffe und Wortgruppen

Autoren-Profil (2019)

W. David Hardy, MD, currently serves as Adjunct Professor of Medicine at Johns Hopkins University School of Medicine and lives in Washington, D.C. His previous professional experience includes serving as Senior Director of Research at Whitman-Walker Health in D.C. (2015-2018), Chief Medical Officer of Calimmune, a translational science company investigating gene-modified cellular therapies as a potential cure for HIV (2013-2015) and Director of the Division of Infectious Diseases at Cedars-Sinai Medical Center and Professor of Medicine at the David Geffen School of Medicine at UCLA (2002-2013). Early in the AIDS epidemic, he completed a clinical fellowship in infectious diseases/immunology and clinical research at the UCLA School of Medicine under the direction of Dr Michael Gottlieb, the physician who recognized and reported the first cases of AIDS. Later he also completed a laboratory fellowship in molecular retrovirology with Irvin Chen, PhD at UCLA. Dr. Hardy has cared for persons with HIV infection since 1982 and conducted research on HIV and related diseases since 1984. Dr Hardy currently serves as Chair of the Board of Directors of the HIV Medicine Association (HIVMA) and Chair of the Education Committee of the American Academy of HIV Medicine (AAHIVM). He has worked with several community-based organizations, including AIDS Research Alliance, Alliance for Housing and Healing, Being Alive-Empowering People with HIV/AIDS, Project Angel Food and AIDS Project Los Angeles. The American Academy of HIV Medicine is a professional organization that supports the HIV practitioners and promotes accessible, quality care for all Americans living with HIV disease. The AAHIVM membership of HIV practitioners and credentialed providers give direct care to the majority of HIV patients in the US. The Academy's HIV-focused professional certifications are the first and only credentials offered domestically and internationally to physicians, nurse practitioners, physician assistants and pharmacists specializing in advanced level HIV care. The HIV SpecialistTM (AAHIVS) credential is available to practicing frontline clinical providers, while the HIV ExpertTM (AAHIVE) designation can be earned by non-practicing clinicians. The HIV PharmacistTM (AAHIVP) certification is available to eligible HIV-specialized pharmacists.

Bibliografische Informationen